Grufity logoGrufity logo

ILMN

205.98USD-7.88(-3.68%)Market Closed

Illumina Inc

Market Summary

USD205.98-7.88Market Closed
-3.68%

ILMN Alerts

ILMN Stock Price

RSI Chart

Valuation

Market Cap

36.7B

Price/Earnings

-1.9K

Price/Sales

7.81

Price/Cashflow

119.38

MarketCap/EBT

4.1K

Price/Sales

Profitability

Operating Margin

67.54%

EBT Margin

0.19%

Return on Equity

-0.18%

Return on Assets

-0.12%

Fundamentals

Revenue

Revenue (TTM)

4.7B

Revenue Y/Y

0.63%

Revenue Q/Q

-4.04%

Earnings

Earnings (TTM)

-4.2B

Earnings Y/Y

-1.3K%

Earnings Q/Q

-613.27%

Price Action

52 Week Range

173.45428.00
(Low)(High)

Last 7 days

-1.2%

Last 30 days

-8.2%

Last 90 days

0.1%

Trailing 12 Months

-41.4%

Financial Health

Current Ratio

1

Investor Care

Shares Dilution (1Y)

0.64%

Diluted EPS (TTM)

-26.43

Peers (Alternatives to Illumina)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
41.1B
6.7B
11.22% 0.39%
30.93
6.17
8.42% 34.14%
36.7B
4.7B
-8.19% -41.42%
-1.9K
7.81
9.79% -558.28%
28.5B
3.9B
13.18% -5.32%
34.68
7.36
7.75% 11.02%
18.1B
2.9B
10.66% 0.37%
25.81
6.25
8.61% 6.30%
17.2B
4.6B
5.21% -24.32%
25.45
3.42
-9.73% -44.26%
MID-CAP
SMALL-CAP
2.0B
137.0M
10.30% -54.93%
-9.53
14.05
12.61% -709.53%
1.1B
159.7M
-11.92% -68.89%
-4.68
6.81
19.67% -35.56%
661.5M
23.3M
-5.68% -35.33%
-6.25
28.36
76.56% -106.44%
488.2M
135.3M
-26.20% -81.34%
-3.51
3.42
-2.59% -32.75%
413.2M
110.0M
29.87% -66.36%
-5.25
3.72
3.37% -106.72%
372.0M
132.7M
-11.99% -82.25%
-19.64
2.76
31.03% -107.73%
122.6M
69.0M
-3.95% -81.13%
-1.31
1.6
-18.80% -75.52%
109.5M
118.0M
3.15% -60.54%
-29.97
0.91
0.97% -269.58%
95.7M
51.6M
1.34% -15.34%
238.75
1.86
20.72% 150.31%

Financials for Illumina

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue0.1%4,6994,6924,6564,5264,280
Cost Of Revenue3.9%1,5831,5231,4521,3721,314
Gross Profit-1.7%3,1163,1693,2043,1542,966
Operating Expenses75.2%7,1274,0683,3373,2772,998
  S&GA Expenses-36.2%1,2902,0232,0262,0921,964
  R&D Expenses-7.7%1,3251,4361,3111,1851,034
Earnings Before Taxes-45466.7%-4,083.0098538841,095
Net Income-21752.6%-4,152.00-19.00701762906
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-27.1%11,25615,44815,27415,21715,063
  Current Assets-14.0%2,4872,8912,7552,7132,451
    Cash Equivalents-22.4%1,0001,2891,3511,2321,080
  Inventory7.9%559518465431401
  Net PPE1.2%1,0681,0551,0341,0241,009
  Goodwill-54.8%3,2387,1587,1137,1137,098
  Current Liabilities-7.4%2,6692,8811,4901,093914
    LT Debt, CurrentInfinity%499----
Shareholder's Equity-35.6%6,73110,44410,89510,74010,593
  Retained Earnings-74.9%1,2815,0975,6325,4855,372
  Additional Paid-In Capital1.1%9,1299,0338,9578,9388,849
Accumulated Depreciation-796----
Shares Outstanding0%157157157152-
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations71.7%527307435545669
  Share Based Compensation-62.8%364978967754922
Cashflow From Investing81.8%-489.00-2,687.00-2,519.00-1,069.00-1,103.00
Cashflow From Financing83.2%-85.00-507.00-998.00-51.00-253.00
  Buy Backs-100.0%0562
* denotes actual numbers (not divided by Millions)

Risks

What is the probability of a big loss on ILMN?

80.8%


Probability that Illumina stock will be more than 20% underwater in next one year

37.3%


Probability that Illumina stock will be more than 30% underwater in next one year.

15.4%


Probability that Illumina stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does ILMN drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Illumina was unfortunately bought at previous high price.

Returns

Cumulative Returns on ILMN

14.9%


10-Year Cumulative Returns

1.8%


7-Year Cumulative Returns

-0.8%


5-Year Cumulative Returns

-14.2%


3-Year Cumulative Returns

What are the long-term rolling returns for ILMN?

FIve years rolling returns for Illumina.

Which funds bought or sold ILMN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-23
Eagle Bay Advisors LLC
ADDED
35.05
7,117
25,000
0.01%
2022-11-23
Toroso Investments, LLC
ADDED
3.64
64,000
939,000
0.04%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
8,930,000
8,930,000
0.10%
2022-11-22
CONTINENTAL INVESTORS SERVICES, INC.
NEW
-
13,407,000
13,407,000
0.49%
2022-11-22
CVA Family Office, LLC
ADDED
53.85
21,000
57,000
0.01%
2022-11-22
B. Riley Wealth Advisors, Inc.
ADDED
61.24
299,000
743,000
0.02%
2022-11-21
FourThought Financial, LLC
ADDED
4,018.67
1,727,000
1,768,000
0.26%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
ADDED
2.11
2,789,000
51,963,000
0.09%
2022-11-21
Parallax Volatility Advisers, L.P.
REDUCED
-6.89
-66,000
1,752,000
-%
2022-11-18
National Pension Service
ADDED
11.14
6,918,000
48,021,000
0.10%

1–10 of 44

Latest Funds Activity

Are funds buying ILMN calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own ILMN

Illumina News

MarketBeat

Illumina, Inc. (NASDAQ:ILMN) Given Average Recommendation of "Hold" by Brokerages.65 minutes ago

ILMN Fair Value

Recent SEC filings of Illumina

View All Filings
Date Filed Form Type Document
Nov 29, 2022
424B2
Prospectus Filed
Nov 29, 2022
FWP
Prospectus Filed
Nov 16, 2022
4/A
Insider Trading
Nov 14, 2022
8-K
Current Report
Nov 08, 2022
4
Insider Trading
Nov 08, 2022
4
Insider Trading
Nov 08, 2022
4
Insider Trading
Nov 08, 2022
4
Insider Trading
Nov 08, 2022
4
Insider Trading
Nov 08, 2022
4
Insider Trading

Latest Insider Trading transactions for ILMN

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-08
Aravanis Alexander
SOLD
-78,698
218
-361
SVP, Chief Technology Officer
2022-11-07
TOUSI SUSAN H
SOLD
-111,825
223.65
-500
SVP, Chief Commercial Officer
2022-11-07
Hoyt Aimee L
SOLD
-289,403
223.65
-1,294
SVP, Chief People Officer
2022-11-07
Hoyt Aimee L
SOLD
-233,714
223.65
-1,045
SVP, Chief People Officer
2022-11-05
deSouza Francis A
SOLD FOR TAXES
-562,739
217.19
-2,591
President and CEO
2022-11-05
TOUSI SUSAN H
SOLD FOR TAXES
-156,594
217.19
-721
SVP, Chief Commercial Officer
2022-11-05
Pegels Kevin Carl
SOLD FOR TAXES
-102,514
217.19
-472
Chief of Global Operations
2022-11-05
Aravanis Alexander
SOLD FOR TAXES
-41,483.3
217.19
-191
SVP, Chief Technology Officer
2022-11-05
Ericksen Scott D
SOLD FOR TAXES
-46,261.5
217.19
-213
VP, Chief Accounting Officer
2022-11-05
GOSWAMI JOYDEEP
SOLD FOR TAXES
-138,567
217.19
-638
SVP Corp Business Development

1–10 of 50

Francis A. deSouza
9800
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

ILMN Income Statement

2022-10-02
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Oct. 02, 2022
Oct. 03, 2021
Oct. 02, 2022
Oct. 03, 2021
Revenue:    
Total revenue$ 1,115$ 1,108$ 3,501$ 3,327
Cost of revenue:    
Amortization of acquired intangible assets461812531
Total cost of revenue3983381,201990
Gross profit7177702,3002,337
Operating expense:    
Research and development325436975835
Selling, general and administrative1468798651,666
Legal contingency and settlement(11)05980
Goodwill impairment3,91403,9140
Total operating expense4,3741,3156,3522,501
Loss from operations(3,657)(545)(4,052)(164)
Other income (expense):    
Interest income3040
Interest expense(6)(14)(17)(48)
Other (expense) income, net(12)979(103)1,010
Total other (expense) income, net(15)965(116)962
(Loss) income before income taxes(3,672)420(4,168)798
Provision for income taxes14410397148
Net (loss) income$ (3,816)$ 317$ (4,265)$ 650
(Loss) earnings per share:    
Basic (in dollars per share)$ (24.26)$ 2.09$ (27.13)$ 4.39
Diluted (in dollars per share)$ (24.26)$ 2.08$ (27.13)$ 4.36
Shares used in computing (loss) earnings per share:    
Basic (in shares)157152157148
Diluted (in shares)157153157149
Product revenue    
Revenue:    
Total revenue$ 963$ 978$ 3,039$ 2,903
Cost of revenue:    
Cost of revenue280264866782
Service and other revenue    
Revenue:    
Total revenue152130462424
Cost of revenue:    
Cost of revenue$ 72$ 56$ 210$ 177

ILMN Balance Sheet

2022-10-02
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Oct. 02, 2022
Jan. 02, 2022
Current assets:  
Cash and cash equivalents$ 1,000$ 1,232
Short-term investments41107
Accounts receivable, net628648
Inventory, net559431
Prepaid expenses and other current assets259295
Total current assets2,4872,713
Property and equipment, net1,0681,024
Operating lease right-of-use assets680672
Goodwill3,2387,113
Intangible assets, net3,3353,250
Other assets448445
Total assets11,25615,217
Current liabilities:  
Accounts payable281332
Accrued liabilities1,142761
Term notes, current portion4990
Convertible senior notes, current portion7470
Total current liabilities2,6691,093
Operating lease liabilities748774
Term notes495993
Convertible senior notes0702
Other long-term liabilities613915
Stockholders’ equity:  
Common stock22
Additional paid-in capital9,1298,938
Accumulated other comprehensive income3917
Retained earnings1,2815,485
Treasury stock, at cost(3,720)(3,702)
Total stockholders’ equity6,73110,740
Total liabilities and stockholders’ equity$ 11,256$ 15,217